Compare companies
Fortis Healthcare Limited | Cipla Limited | Biocon Limited | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 645.35 | 1475.5 | 348.3 | |||
Price priv. | ||||||
Number of shares, million | 754.96 | 807.37 | 1196.8 | |||
Capitalization, billion | 229.85 | 846.5 | 299.31 | |||
EBITDA, billion | 12.59 | 53.2 | 24.29 | |||
EV, billion | 311.72 | 820.34 | 446.74 | |||
Profit and loss report | ||||||
Net profit, billion | 5.99 | 41.22 | 10.23 | |||
Revenue, billion | 68.35 | 254.47 | 141.96 | |||
EPS | 7.93 | 51.05 | 8.54 | |||
Balance | ||||||
Assets, billion | 132.89 | 327.18 | 560.71 | |||
Debt, billion | 8.58 | 3.85 | 157.3 | |||
Balance cost, billion | 76.63 | 267.06 | 197.84 | |||
Cash, billion | 2.35 | 6.4 | 12.33 | |||
Coefficients | ||||||
Dividend yield, % | 0.3961 | 0.5498 | 0.4195 | |||
Dividend | 1 | 13 | 0.5 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 14.37 | 16.65 | 19.85 | |||
P/S | 4.47 | 4.7 | 2.13 | |||
P/BV | 3.57 | 4.46 | 1.19 | |||
P/E | 51.01 | 29.01 | 29.51 | |||
Ev/Ebitda | 15.79 | 17.88 | 16.97 | |||
Debt/Ebitda | 0.682 | 0.0724 | 6.48 | |||
Efficiency | ||||||
ROE | 8.04 | 16.45 | 5.43 | |||
ROA | 4.66 | 13.26 | 1.89 | |||
ROIC | 8.33 | 14.66 | 1.86 | |||
Ebitda margin | 18.41 | 20.91 | 17.11 | |||
Net margin | 8.76 | 16.2 | 7.2 | |||
Momentum | ||||||
1 week, price changes | +7 % | -3.01 % | +0.4839 % | |||
1 month, price changes | +10.27 % | +0.2939 % | +6.71 % | |||
3 months, price changes | -0.1711 % | -1.45 % | -1.1 % | |||
6 months, price changes | +12.13 % | -12.21 % | -7.07 % | |||
1 year, price changes | +62.44 % | +0.0921 % | +33.53 % | |||
3 years, price changes | +139.57 % | +42.61 % | +0.1022 % | |||
5 years, price changes | +325.77 % | +230.86 % | +11.69 % | |||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription